Maria Giovanna Scarale
Overview
Explore the profile of Maria Giovanna Scarale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pezzilli S, Mazza T, Scarale M, Tang Y, Andreozzi F, Baroni M, et al.
Acta Diabetol
. 2022 Feb;
59(5):747-750.
PMID: 35112188
No abstract available.
12.
Scarale M, Antonucci A, Cardellini M, Copetti M, Salvemini L, Menghini R, et al.
J Clin Endocrinol Metab
. 2021 Jun;
106(11):e4350-e4359.
PMID: 34192323
Context: Type 2 diabetes (T2D) shows a high mortality rate, partly mediated by atherosclerotic plaque instability. Discovering novel biomarkers may help identify high-risk patients who would benefit from more aggressive...
13.
Antonucci A, Marucci A, Scarale M, De Bonis C, Mangiacotti D, Trischitta V, et al.
Int J Obes (Lond)
. 2021 Mar;
45(6):1362-1366.
PMID: 33658684
3T3L1 mouse pre-adipocytes develop into adipocytes differently in response to GALNT2 overexpression or to stimulation with rosiglitazone, a reference inducer of adipogenesis. To investigate the biology of alternative pathways of...
14.
Garofolo M, Gualdani E, Scarale M, Bianchi C, Aragona M, Campi F, et al.
Diabetes Care
. 2020 Aug;
43(10):e139-e141.
PMID: 32796028
No abstract available.
15.
Scarale M, Copetti M, Garofolo M, Fontana A, Salvemini L, De Cosmo S, et al.
Diabetes Care
. 2020 Mar;
43(5):1025-1032.
PMID: 32144164
Objective: Type 2 diabetes is characterized by increased death rate. In order to tackle this dramatic event, it becomes essential to discover novel biomarkers capable of identifying high-risk patients to...
16.
Copetti M, Shah H, Fontana A, Scarale M, Menzaghi C, De Cosmo S, et al.
J Clin Endocrinol Metab
. 2019 May;
104(10):4900-4908.
PMID: 31087060
Context: We previously developed and validated an inexpensive and parsimonious prediction model of 2-year all-cause mortality in real-life patients with type 2 diabetes. Objective: This model, now named ENFORCE (EstimatioN...
17.
Marucci A, Antonucci A, De Bonis C, Mangiacotti D, Scarale M, Trischitta V, et al.
Int J Obes (Lond)
. 2019 May;
43(12):2448-2457.
PMID: 31040393
Background/objectives: A better understanding of adipose tissue biology is crucial to tackle insulin resistance and eventually coronary heart disease and diabetes, leading causes of morbidity and mortality worldwide. GALNT2, a...
18.
Scarale M, Fontana A, Trischitta V, Copetti M, Menzaghi C
J Clin Endocrinol Metab
. 2018 Nov;
PMID: 30388239
Context: Some studies have surprisingly indicated that serum adiponectin is positively related to mortality rate, thus casting doubts on its role as a therapeutic target for cardiovascular disease. Objective: To...
19.
Ghiglietti A, Scarale M, Miceli R, Ieva F, Mariani L, Gavazzi C, et al.
J Biopharm Stat
. 2018 Mar;
28(6):1203-1215.
PMID: 29565749
Recently, response-adaptive designs have been proposed in randomized clinical trials to achieve ethical and/or cost advantages by using sequential accrual information collected during the trial to dynamically update the probabilities...
20.
Pezzilli S, Ludovico O, Biagini T, Mercuri L, Alberico F, Lauricella E, et al.
Diabetes
. 2017 Oct;
67(1):137-145.
PMID: 28993341
Multigenerational diabetes of adulthood is a mostly overlooked entity, simplistically lumped into the large pool of type 2 diabetes. The general aim of our research in the past few years...